ESR1 and osteoporosis: Therapeutic agents for clinically diagnosed osteoporosis include bisphosphonates, selective estrogen receptor modulators, and hormone replacement therapy, but the side effects and long-term efficacy of the drugs have yet to be proven, limiting their use in clinical practice [33, 34].